Receptor profile
ER, PR, HER2, Ki-67 and repeat biopsy results if metastatic disease was re-biopsied are reviewed.
Oncology evaluation directory
Breast oncology
Breast Cancer Evaluation
A breast oncology review organized around receptor status, stage, pathology, prior surgery, chemotherapy, radiation, endocrine or anti-HER2 therapy, metastatic pattern and current treatment objective.
Medical disclaimer: This page is informational and coordination-focused. It does not diagnose, prescribe, promise treatment suitability or replace urgent local medical care.
Clinical file logic
What the specialist needs to understand before any treatment discussion.
Breast cancer review begins with receptor status. ER-positive/HER2-negative, HER2-positive and triple-negative disease can require very different interpretation. The file must also show whether the disease is early, recurrent or metastatic.
The coordination process organizes pathology, imaging and treatment chronology so the specialist can evaluate the current question rather than re-reading years of documents without structure.
Stage and sites
Breast/axillary disease, bone, liver, lung, brain or other metastatic sites are summarized.
Prior local therapy
Surgery type, lymph node surgery, radiation and margins are documented.
Systemic timeline
Chemotherapy, endocrine therapy, CDK4/6 inhibitors, anti-HER2 therapy, immunotherapy or other treatments are listed.
Disease behavior
Response, progression date, tumor marker trend and visceral crisis concerns are reviewed.
Patient condition
Pain, fatigue, organ function, menopausal status and treatment tolerance are included.
Evaluation matrix
How the case is reviewed without reducing it to a diagnosis name.
Each item below affects how the file is interpreted, what the physician can answer and whether additional documents are needed before a responsible response.
Receptor status controls interpretation
Current ER/PR/HER2 status should not be assumed from old reports if disease biology changed.
Metastatic site matters
Bone-only disease and rapidly progressive liver/lung disease require different urgency framing.
Treatment sequence
Prior endocrine, HER2-directed or chemotherapy exposure affects next-step discussions.
Symptoms and function
Pain, anemia, liver function and performance status can change timing.
Documents to prepare
A complete medical file prevents delay and unrealistic expectations.
Most delays happen when the diagnosis is described verbally but the file lacks dates, reports, imaging, pathology or the current specialist recommendation. The documents below are requested before the file is considered ready for review.
Cuba context
How Cuba-related options are framed responsibly.
The page does not present a hospital visit or travel plan as automatically suitable. Any Cuba-related discussion remains conditional on physician review of the current file.
Subtype-specific review
The case is not reviewed as generic breast cancer; receptor and stage context lead the routing.
Current biopsy may matter
When disease has recurred or metastasized, updated pathology can change interpretation.
Coordination remains non-prescriptive
CHA organizes the case; the medical team determines suitability and route.
When local care comes first
Do not wait for international review if urgent symptoms are present.
International coordination should never delay emergency care. If any of the following are present, the patient should be assessed locally first.
- Severe shortness of breath, chest pain, confusion or rapidly worsening weakness.
- New neurological symptoms or severe headache.
- Severe bone pain, suspected fracture, jaundice or uncontrolled infection.
Coordination pathway
From records to written next steps.
- File intakeReports, imaging, summaries and current symptoms are uploaded through the application flow.
- Quality checkThe coordination team checks readability, dates, translation needs and missing items.
- Specialist routingThe case is prepared around a clear medical question and routed to the relevant review pathway.
- Written responseThe patient receives an organized next-step explanation before travel, payment or treatment logistics are considered.
Questions
Before starting the application.
Does this page mean I am suitable for a Cuba-based treatment?
No. It explains how the file is organized for review. Suitability, route, timing and safety can only be determined by physicians after reviewing the complete current record.
Can I send only a short summary?
A summary helps, but it is not enough for most oncology reviews. Pathology, imaging, treatment history, lab results and the latest oncology note are usually needed.
Will the coordinator choose my treatment?
No. Cuba Health Assist coordinates records, communication, translation support and logistics. Medical decisions remain with licensed physicians and the patient’s treating team.
What happens if my file is incomplete?
The team will request missing reports before presenting the case as ready. This protects the patient from receiving a weak or unrealistic response.
Can urgent symptoms be handled through this page?
No. Severe or rapidly worsening symptoms require local emergency or oncology care first. International coordination is not an emergency service.
Related evaluation pages
Other oncology files reviewed in the same clinical directory.
Start with the file
Submit documents before making a travel or treatment decision.
A coordinator will organize the medical information and guide the next step according to specialist review. The process is designed to be transparent, clinically cautious and written.